Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
17.9
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.No category-specific facts could be extracted from this document.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上高は、2024年11月に取得したONE MEDICALの連結開始やSaaS・DX事業の伸長により増加した。利益面では、売上成長を優先してオンライン診療・カウンセリングを中心に広告宣伝費を積極的に投下し、人材採用・昇給などで人件費も増加したため営業利益が減少した。純利益はM&A・融資関連費149百万円と特別損失148百万円の計上により減少した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.